Boswella Cream — topical boswellic acid formula with liposomal delivery. Plant-based anti-inflammatory support for joint pain, skin inflammation, and natural wellness protocols.
Boswella Cream is a topical anti-inflammatory formulated with boswellic acids — the active compounds extracted from Boswellia serrata resin — delivered through a liposomal system that enhances penetration into the skin and underlying tissues. Boswellic acids work through a different pathway than NSAIDs, blocking the 5-lipoxygenase (5-LOX) enzyme that drives leukotriene-mediated inflammation. The result is targeted local anti-inflammatory support without systemic NSAID exposure.
| Specification | Detail |
|---|---|
| Active ingredient | Boswellic Acids (Boswellia serrata extract) |
| Delivery system | Liposomal — enhanced skin penetration |
| Form | Topical cream |
| Regulatory status | OTC dietary supplement topical |
| Private label | Available |
| Storage | Room temperature; away from direct heat and sunlight |
Legere supplies licensed medical practices with a range of quantities to fit your volume needs. To get pricing, check availability, or place an order, click Request a Quote above or contact our team directly. Private label options are available on select products.
Boswellic acids — particularly AKBA (acetyl-11-keto-beta-boswellic acid), the most potent active compound — selectively inhibit 5-lipoxygenase (5-LOX). 5-LOX is the enzyme responsible for producing leukotrienes, a class of inflammatory mediators that drive joint inflammation, swelling, and pain. By blocking this enzyme, boswellic acids reduce the inflammatory signaling that causes discomfort in arthritic joints and inflamed soft tissue.
This mechanism is distinct from how NSAIDs work. NSAIDs block COX-1 and COX-2 enzymes, which is why they carry GI and cardiovascular risks. Boswellic acids target the leukotriene pathway instead — a complementary but different route to anti-inflammatory effect, and one without the systemic side effect profile of NSAID therapy.
Pain management and integrative medicine practices: Boswella Cream is a natural complement to an injectable steroid and NSAID formulary. For patients who prefer plant-based anti-inflammatory options, or who are not candidates for systemic NSAIDs, a topical boswellia product provides a meaningful clinical option that fits within a comprehensive pain management toolkit.
Aesthetic and functional medicine practices: Boswellia’s anti-inflammatory properties extend to skin inflammation — redness, irritation, and inflammatory skin conditions. Aesthetic practices looking to offer natural anti-inflammatory topical support alongside their treatment menu find Boswella Cream a natural addition.
GLP-1 and weight loss practices: Low-grade chronic inflammation is a well-documented feature of metabolic dysfunction and obesity. Practices managing metabolic health comprehensively may incorporate anti-inflammatory topical support alongside systemic approaches.
Wellness and longevity practices: Practices with a natural health orientation that want to offer evidence-informed plant-based products alongside pharmaceutical options. Boswella Cream bridges the gap between supplement-based and pharmaceutical anti-inflammatory approaches.
DHEA 25mg Capsules — DHEA supports adrenal hormone precursors that play a role in the body’s inflammatory regulatory response. Practices addressing inflammation from a holistic hormonal standpoint may combine Boswella™ Cream topically with DHEA supplementation for broader systemic support.
Sermorelin Acetate Injection — For anti-aging and longevity practices: GH support via Sermorelin and leukotriene modulation via Boswellia address complementary aspects of the cellular aging and tissue maintenance picture.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For external use only: Apply to skin only. Avoid contact with eyes and mucous membranes.
Skin sensitivity: As with any topical product, a small patch test before widespread application is recommended for patients with known skin sensitivities.
Pregnancy and breastfeeding: Insufficient data for topical boswellia use during pregnancy or breastfeeding. Use with appropriate clinical caution.
Drug interactions: No clinically significant topical drug interactions are established for boswellic acids. Patients on systemic anti-inflammatory or anticoagulant therapy should discuss any new topical anti-inflammatory product with their provider as part of routine care.
For use by licensed medical and wellness practices.
How do I order, and what quantities are available?
Contact our team directly to place an order or request a quote. We supply a range of quantities depending on the product — reach out for current availability, lead times, and volume pricing. Private label options are available.
What makes the liposomal delivery in Boswella Cream different from a standard boswellia cream?
Boswellic acids are fat-soluble and do not penetrate the skin’s water-based outer layer easily in a standard formulation. Liposomal delivery encapsulates the boswellic acids in tiny fat-based spheres that carry the active compounds through the skin barrier into the deeper tissue layers where inflammation is occurring. The result is substantially better local bioavailability compared to a standard boswellia topical.
How does Boswella Cream differ from topical NSAIDs like diclofenac gel?
Diclofenac gel is a prescription NSAID that works by blocking COX enzymes — the same pathway as ibuprofen and aspirin. Boswella Cream works through the 5-LOX enzyme pathway, targeting leukotriene-mediated inflammation instead. They address inflammation through complementary mechanisms and are not interchangeable, but they can be used alongside each other in a comprehensive pain management approach.
Is private label available for Boswella Cream?
Yes. Contact our team to discuss private label options, minimum order quantities, and label customization for your practice.
Are there any drug interactions to be aware of?
No clinically significant topical drug interactions for boswellic acids are currently established. Patients on systemic anti-inflammatory or blood thinning medications should mention any new topical products to their provider as part of routine care.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For use by licensed medical and wellness practices.
Schedule a no obligation/no-pressure call to quickly increase your weight loss clinic’s revenue.
